The ''bioartificial pancreas'' is a special technique of islet transpl
antation, separating the transplanted tissue from the donor's immune s
ystem by an artificial membrane. Thus, the necessity of a permanent im
munosuppressive drug therapy may be avoided. In vivo, a significant pr
olongation of the graft survival either in an allogeneic or in a xenog
eneic strain combination has been shown in animals. But, islets inside
the capsule are able to stimulate lymphocyte proliferation in vitro,
probably dependent on the molecular cut off of the membrane. Moreover,
the immunological interaction between the capsule material and the re
cipient (biocompatibility) has to be considered.